Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allergan Moves Up on Low Volume
Yahoo/Zacks.com
Monday, April 27, 2009 - 4:02pm
tags:
Allergan
Earnings Preview: Bristol Myers Squibb
Seeking Alpha
Monday, April 27, 2009 - 3:36pm
tags:
earnings, Bristol-Myers Squibb
Earnings Preview: Pfizer
Seeking Alpha
Monday, April 27, 2009 - 3:35pm
tags:
Pfizer, earnings
Dynavax Surge Not Warranted
Yahoo/AP
Monday, April 27, 2009 - 3:22pm
tags:
Dynavax, Heplivsav
Nexavar Fails in Phase III Skin Cancer Trial
TheStreet.com
Monday, April 27, 2009 - 11:59am
tags:
Nexavar, drug trials, skin cancer, ONYX Pharmaceuticals
Glenmark unit gets first nod for Zetia generic
Economic Times, India
Monday, April 27, 2009 - 11:56am
tags:
Zetia, Glenmark, generics, India, FDA, cholesterol
Sepracor Reports Preliminary Phase III Study Results for OMNARIS HFA Nasal Aerosol in Seasonal Allergic Rhinitis
Yahoo
Monday, April 27, 2009 - 11:54am
tags:
Sepracor, allergic rhinitis.Omnaris, drug trials
Alexion - How Long a 1-Drug Wonder?
Yahoo/Zacks.com
Monday, April 27, 2009 - 11:47am
tags:
Alexion, Soliris
Allos Therapeutics: Smallcap Biotech with FDA Catalyst
Seeking Alpha
Monday, April 27, 2009 - 11:46am
tags:
Allos, cancer, FDA, biotech
Novartis Drug Heralds Era of New Multiple Sclerosis Therapies
Bloomberg
Monday, April 27, 2009 - 11:45am
tags:
Novartis, MS, multiple sclerosis
Merck selects UTSA, Health Science Center to develop vaccine
Bizjournals.com
Monday, April 27, 2009 - 11:35am
tags:
Merck, UTSA, vaccines
Glaxo, Roche Start to Map Swine-Flu Game Plans
WSJ Online
Monday, April 27, 2009 - 11:32am
tags:
GSK, Roche, swine flu, Flu, Tamiflu, RELENZA
Pfizer, Bristol-Myers to report earnings Tuesday
Marketwatch
Monday, April 27, 2009 - 10:49am
tags:
Pfizer, Bristol-Myers Squibb, earnings
XenoPort, Glaxo pain drug fails in midstage study
Yahoo/AP
Monday, April 27, 2009 - 10:47am
tags:
XenoPort, GSK, painkillers, drug trials
Dendreon's Provenge: Moment of Truth
TheStreet.com
Monday, April 27, 2009 - 10:45am
tags:
Dendreon, Provenge, prostate cancer
Merck: It's Not All Crystal Clear
Forbes
Monday, April 27, 2009 - 10:40am
tags:
Merck KGaA
Swine Flu Fears Shake Markets
Forbes
Monday, April 27, 2009 - 10:39am
tags:
swine flu, Flu
GlaxoSmithKline: Witty's Management Is Reason for Optimism
Seeking Alpha
Monday, April 27, 2009 - 10:33am
tags:
GSK, Andrew Witty, Pharma CEOs
Statins Shown to Cut Prostate-Cancer Risk
WSJ Online
Monday, April 27, 2009 - 10:32am
tags:
prostate cancer, statins
Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Pe
PR Canada, Canada
Sunday, April 26, 2009 - 12:24pm
tags:
Sinobiopharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.